NCT01450020

Brief Summary

This randomized clinical trial studies peer navigator education in improving survivorship care in African American breast cancer survivors. An educational intervention involving peer groups may help to improve the well-being and quality of life (QOL) in breast cancer survivors

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
145

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 12, 2011

Completed
8 months until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
13.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

13.6 years

First QC Date

October 6, 2011

Last Update Submit

July 16, 2025

Conditions

Keywords

cancer survivor

Outcome Measures

Primary Outcomes (2)

  • Ability of peer navigation to improve understanding of SCP

    Chi-square and t-tests will be used to compare the baseline characteristics of subjects randomized to PN intervention vs control. For subjects in the intervention arm, the number of navigation sessions received will be reported, and correlated factors will be explored. The number of subjects navigated per PN will also be reported. Nonevaluable and evaluable subjects (defined at 6 and 12 months) will be compared. Site of care will be handled as a cluster level variable in generalized linear mixed (GLM) regression models.

    At 6 months

  • Adherence to the SCP schedule of follow-up examinations

    Measured using a newly created, 50-point scale that gives equal weight to completion of the recommended: physical exams, imaging, pelvic exam, annual oncology visit, and breast self-exams.

    At 12 months

Secondary Outcomes (3)

  • Effect of PN on change in medical efficacy

    Baseline to 6 months

  • Preparedness for life as new survivor (PLANS)

    At 6 months

  • Physical and health related QOL

    At 6 months

Study Arms (2)

Arm I (PN and ACS material)

EXPERIMENTAL

Participants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and ACS materials.

Other: educational interventionOther: questionnaire administrationOther: counseling interventionOther: survey administrationProcedure: quality-of-life assessment

Arm II (ACS material)

ACTIVE COMPARATOR

Participants receive ACS materials only.

Other: educational interventionOther: questionnaire administrationOther: survey administrationProcedure: quality-of-life assessment

Interventions

Receive ACS material

Also known as: intervention, educational
Arm I (PN and ACS material)Arm II (ACS material)

Ancillary studies

Arm I (PN and ACS material)Arm II (ACS material)

Undergo PN session

Also known as: counseling and communications studies
Arm I (PN and ACS material)

Ancillary studies

Arm I (PN and ACS material)Arm II (ACS material)

Ancillary studies

Also known as: quality of life assessment
Arm I (PN and ACS material)Arm II (ACS material)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • TRIAL SUBJECTS:
  • Patient age 18 years or older who self-identifies as African-American
  • In early survivorship phase, defined as being 1-12 months post completion of treatment for stage 0-3 breast cancer
  • Receiving health care primarily through an health maintenance organization (HMO)
  • Patients with metastatic cancer or a second primary cancer, because their medical characteristics (e.g. disease progression) are significantly different
  • Breast cancer survivors (BCS) with other major disabling medical, psychiatric, or substance abuse conditions (e.g., anxiety, depression, alcohol/tobacco problems) will be excluded
  • PEER NAVIGATORS:
  • At least 25 years of age who self-identifies as African-American
  • Previously participated in any type of research study
  • Has at least high school education
  • Has been diagnosed with breast cancer, currently in remission or eradicated
  • Belongs to a breast cancer support group
  • Has a valid driver's license
  • Owns an operational vehicle
  • Has access to a personal computer with internet access

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

City of Hope Medical Center

Duarte, California, 91010, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Early Intervention, EducationalMethodsCounseling

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesInvestigative TechniquesMental Health ServicesBehavioral Disciplines and Activities

Study Officials

  • Kimlin Ashing-Giwa

    City of Hope Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2011

First Posted

October 12, 2011

Study Start

June 1, 2012

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

July 18, 2025

Record last verified: 2025-07

Locations